CIGA Healthcare

CIGA Healthcare is a British manufacturer of lateral flow assay diagnostic tests.[1] It is under contract to the British government for the supply of AbC-19 rapid antibody tests,[2] a test for the presence of IgG antibody against the SARS-CoV-2 spike protein,[3] as part of the UK Rapid Test Consortium program.[4]

Distribution

CIGA Healthcare will be responsible for assembly and distribution of the AbC-19 rapid antibody tests, and has also been awarded distribution in the US after recent FDA approval.[5]

References
  1. "Abingdon Health announces its latest expansion and additional manufacturing capacity". Lifescience Industry News. 18 June 2020. Retrieved 12 November 2020.
  2. "Government invests in UK-developed antibody tests from UK Rapid Test Consortium". GOV.UK. Retrieved 12 November 2020.
  3. Gill, Dipender; Ponsford, Mark J. (11 November 2020). "Testing for antibodies to SARS-CoV-2". BMJ. 371. doi:10.1136/bmj.m4288. ISSN 1756-1833.
  4. Symon, Ken (19 October 2020). "Medical diagnostics company signs deal on delivery of Covid-19 tests". businessInsider. Retrieved 12 November 2020.
  5. "Yorkshire developed Covid-19 test approved for use in North America | TheBusinessDesk.com". Yorkshire. 17 November 2020. Retrieved 13 April 2021.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.